Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AST-120 in Antibiotic-Refractory Pouchitis
NCT00583531Phase 2Terminated
- Sponsor
- Ocera Therapeutics
- Start
- Mar 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of activated charcoal in pouchitis, sponsored by Ocera Therapeutics. Started Mar 2007; status: terminated.
02
Drugs
activated charcoal
03
Conditions
pouchitis
Beyond the preview
Go deeper on NCT00583531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00583531.